Outlook Therapeutics, Inc. (OTLK) SEC Filings — 2024

Filings

• Outlook Therapeutics Files 8-K on Financials — 8-K · Dec 27, 2024
• Outlook Therapeutics Files 2024 10-K — 10-K · Dec 27, 2024
• Outlook Therapeutics Sells ONS-5010 Assets — 8-K · Dec 16, 2024
• Outlook Therapeutics Appoints New CMO, Director — 8-K · Dec 4, 2024
• Outlook Therapeutics Files 8-K — 8-K · Nov 27, 2024
• Outlook Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Outlook Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 7, 2024
• Outlook Therapeutics Sells ONS-5010 for $15M+ — 8-K · Aug 14, 2024
• Outlook Therapeutics Reports Q3 Loss, Cash Position — 10-Q · Aug 14, 2024
• Outlook Therapeutics Sells ONS-5010 Assets for $15M+ — 8-K · Jul 8, 2024
• Outlook Therapeutics Files Definitive Proxy Statement — DEF 14A · Jun 26, 2024
• Outlook Therapeutics Sells ONS-5010 Assets — 8-K · May 28, 2024
• Outlook Therapeutics Sells ONS-5010 for $15M — 8-K · May 15, 2024
• Outlook Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
• Outlook Therapeutics Sells ONS-5010 for $10M Cash — 8-K · May 13, 2024
• Outlook Therapeutics Partners with Syner-Med for ONS-5010 Launch — 8-K · May 1, 2024
• Syntone Ventures LLC Amends Stake in Outlook Therapeutics — SC 13D/A · Apr 17, 2024
• Outlook Therapeutics Raises $10M in Stock Offering — 8-K · Apr 15, 2024
• Outlook Therapeutics Sells ONS-5010 Assets — 8-K · Apr 12, 2024
• Outlook Therapeutics, Inc. SC 13G Filing — SC 13G · Apr 8, 2024
• Outlook Therapeutics Partners with Syner-Med for ONS-5010 Launch — 8-K · Apr 2, 2024
• Outlook Therapeutics, Inc. SC 13G Filing — SC 13G · Mar 28, 2024
• Outlook Therapeutics, Inc. SC 13G Filing — SC 13G · Mar 28, 2024
• Outlook Therapeutics Appoints New Chief Medical Officer — 8-K · Mar 26, 2024
• GMS Ventures & Investments Amends Outlook Therapeutics Filing — SC 13D/A · Mar 20, 2024
• Outlook Therapeutics Raises $10M in Registered Direct Offering — 8-K · Mar 18, 2024
• Outlook Therapeutics Files 8-K with Corporate Updates — 8-K · Mar 7, 2024
• Outlook Therapeutics Files 8-K on Financial Condition and Results — 8-K · Feb 14, 2024
• Outlook Therapeutics, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 14, 2024
• Outlook Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Feb 8, 2024
• Tenshi Healthcare Amends Outlook Therapeutics Stake (19th Update) — SC 13D/A · Jan 31, 2024
• Outlook Therapeutics Reports Material Agreement, Equity Sales — 8-K · Jan 24, 2024
• Outlook Therapeutics, Inc. Files 10-K/A Amendment for Fiscal Year Ended September 30, 2023 — 10-K/A · Jan 24, 2024